Lisa Swanson, MD: Insights on Maximum-use of Ruxolitinib Cream in Pediatric Patients with Atopic Dermatitis
Lisa Swanson, MD, JCAD’s Section Editor of Pediatric Dermatology, shares her thoughts on new research evaluating maximum-use conditions for topical ruxolitinib cream in pediatric patients (2 to 11 years) with atopic dermatitis.
Melodie Young, MSN, RN, ANP-C: Treating Pediatric Patients with Atopic Dermatitis
Melodie Young discusses managing treatment for younger children with atopic dermatitis, emphasizing the importance of focusing on potential and probable side effects with their caregivers.
Melodie Young, MSN, RN, ANP-C: Practical Aspects of Treating Patients with Atopic Dermatitis
Melodie Young discusses the logistics of gaining access to newer medications through speciality pharmacies for patients with atopic dermatitis.
Andrea Nguyen, PA-C, MS: Treatment Education for Patients with Atopic Dermatitis
Andrea Nguyen, PA-C, MS, discusses how the internet and social media has contributed to more in-depth discussion with her patients regarding treatment for atopic dermatitis.
TJ Chao, PA-C: Considering Adverse Events in Patients with Atopic Dermatitis
TJ Chao breaks down the black box warnings for ruxolitinib cream 1.5% and discusses the importance in communicating the specifics of these warnings to patients.